Literature DB >> 25496331

A promising CpG adjuvant-loaded nanoparticle-based vaccine for treatment of dust mite allergies.

Aliasger K Salem.   

Abstract

Entities:  

Keywords:  CpG; Der p2; PLGA; allergy; asthma; biodegradable; house dust mite allergens; nanoparticles

Mesh：

Substances：

Year:  2014        PMID： 25496331     DOI： 10.2217/imt.14.97

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.040


× No keyword cloud information.
  10 in total

Review 1.  Advances in nanotechnology and asthma.

Authors:  Lingwei Wang; Mengjie Feng; Qiuwen Li; Chen Qiu; Rongchang Chen
Journal:  Ann Transl Med       Date:  2019-04

2.  New perspectives in nanotherapeutics for chronic respiratory diseases.

Authors:  Adriana Lopes da Silva; Fernanda Ferreira Cruz; Patricia Rieken Macedo Rocco; Marcelo Marcos Morales
Journal:  Biophys Rev       Date:  2017-09-15

3.  Nanotechnology bring a new hope for asthmatics.

Authors:  Wen-Chien Cheng; Chia-Hung Chen
Journal:  Ann Transl Med       Date:  2019-10

4.  How will nanotechnology lead to better control of asthma?

Authors:  Bumhee Yang; Hayoung Choi; Sang-Heon Kim; Ho Joo Yoon; Hyun Lee
Journal:  Ann Transl Med       Date:  2019-10

5.  Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them.

Authors:  Maryam Zamani Sani; Afshar Bargahi; Niloofar Momenzadeh; Parva Dehghani; Maryam Vakili Moghadam; Soheila June Maleki; Iraj Nabipour; Afshin Shirkani; Javad Akhtari; Khashayar Hesamizadeh; Sahel Heidari; Fatemeh Omrani; Samad Akbarzadeh; Mohsen Mohammadi
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-20       Impact factor: 4.813

Review 6.  Nanotechnology in respiratory medicine.

Authors:  Albert Joachim Omlor; Juliane Nguyen; Robert Bals; Quoc Thai Dinh
Journal:  Respir Res       Date:  2015-05-29

Review 7.  CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies.

Authors:  Nobutaka Hanagata
Journal:  Int J Nanomedicine       Date:  2017-01-16

Review 8.  Recent applications and strategies in nanotechnology for lung diseases.

Authors:  Wenhao Zhong; Xinyu Zhang; Yunxin Zeng; Dongjun Lin; Jun Wu
Journal:  Nano Res       Date:  2021-01-08       Impact factor: 8.897

9.  Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses.

Authors:  Isabella Radauer-Preiml; Ancuela Andosch; Thomas Hawranek; Ursula Luetz-Meindl; Markus Wiederstein; Jutta Horejs-Hoeck; Martin Himly; Matthew Boyles; Albert Duschl
Journal:  Part Fibre Toxicol       Date:  2016-01-16       Impact factor: 9.400

10.  Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4+ T Cell-Independent CD8+ T-Cell Response Against Unconjugated Protein Antigen.

Authors:  Ana L Chiodetti; María F Sánchez Vallecillo; Joseph S Dolina; María I Crespo; Constanza Marin; Stephen P Schoenberger; Daniel A Allemandi; Santiago D Palma; María C Pistoresi-Palencia; Gabriel Morón; Belkys A Maletto
Journal:  Front Immunol       Date:  2018-10-10       Impact factor: 8.786
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.